Cancer Family
Squamous Cell Neoplasm
CI-CAN-00000359Explore in graph →
Non-malignant1,024 active trials9 approved drugs78 evidence items
Loading cancer entity…
Cancer Family
CI-CAN-00000359Explore in graph →
Clinical trials
3,210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00041613 | Study to Compare the Overall Survival of Patients Receiving INGN 201 (Study Drug) With Patients Receiving Methotrexate | unknown | Phase 3 | — | Introgen TherapeuticsINDUSTRY | 1 | Apr 1, 2008 | clinicaltrials |
| NCT00384124 | Topical Imiquimod for Bowen's Disease of the Head and Neck | unknown | Phase 2 / Phase 3 | 50 | Brooke Army Medical CenterFED | 1 | Mar 26, 2008 | clinicaltrials |
| NCT00559351 |
| RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus |
| terminated |
| Phase 3 |
| 84 |
| Ministry of Scientific Research and Information Technology, PolandOTHER_GOV |
| 1 |
| Nov 16, 2007 |
| clinicaltrials |
| NCT00539630 | TAX + Cisplatin + 5 F/U vs Cisplatin + 5 F/U in SCCHN | completed | Phase 3 | 86 | SanofiINDUSTRY | 1 | Oct 4, 2007 | clinicaltrials |
| NCT00041626 | Effectiveness and Safety of INGN 201 in Combination With Chemotherapy Versus Chemotherapy Alone | unknown | Phase 3 | — | Introgen TherapeuticsINDUSTRY | 1 | Sep 11, 2007 | clinicaltrials |
| NCT00201279 | Chemoprevention Study of Oral Cavity Squamous Cell Carcinoma | completed | Phase 3 | 342 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 20, 2005 | clinicaltrials |
| NCT00201383 | Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients | completed | Phase 3 | 161 | National Health Research Institutes, TaiwanOTHER | 1 | Sep 20, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 1, 2008source: clinicaltrials